Document Detail


The ever-expanding role of degradation in the regulation of apolipoprotein B metabolism.
MedLine Citation:
PMID:  19050312     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Apolipoprotein B (apoB) is the essential protein required for the assembly and secretion of chylomicrons from the small intestine and VLDLs from the liver. These lipoproteins, as well as their remnants and LDL, play key roles in the transport of dietary and endogenously synthesized lipids throughout the body. However, they can be involved in the initiation of atherosclerotic lesions in the vessel wall. Therefore, it is not surprising that the assembly of apoB-containing lipoproteins in the small intestine and liver is a highly regulated process. In particular, cotranslational and posttranslational targeting of apoB for degradation, regulated largely by the availability of the core lipids carried in the lipoprotein, by the types of dietary fatty acids consumed, and by the hormonal milieu, determines the number of chylomicrons or VLDL that are secreted. In this review, we summarize both older and more recent findings on the pathways of apoB degradation, focusing on events in the liver.
Authors:
Henry N Ginsberg; Edward A Fisher
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Review     Date:  2008-12-02
Journal Detail:
Title:  Journal of lipid research     Volume:  50 Suppl     ISSN:  0022-2275     ISO Abbreviation:  J. Lipid Res.     Publication Date:  2009 Apr 
Date Detail:
Created Date:  2009-04-06     Completed Date:  2009-06-05     Revised Date:  2010-09-22    
Medline Journal Info:
Nlm Unique ID:  0376606     Medline TA:  J Lipid Res     Country:  United States    
Other Details:
Languages:  eng     Pagination:  S162-6     Citation Subset:  IM    
Affiliation:
Department of Medicine, Columbia University, College of Physicians and Surgeons, New York, NY 10032, USA. hng1@columbia.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Apolipoproteins B / metabolism*
Biological Transport
Endoplasmic Reticulum / metabolism
Fatty Acids / metabolism
Humans
Insulin / metabolism
Grant Support
ID/Acronym/Agency:
HL-55638/HL/NHLBI NIH HHS; HL-58541/HL/NHLBI NIH HHS; HL-73030/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
0/Apolipoproteins B; 0/Fatty Acids; 11061-68-0/Insulin
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The role of adaptive T cell immunity in atherosclerosis.
Next Document:  Imaging of lipid species by MALDI mass spectrometry.